Want to see HK:3983 full AI Analyst Report?
Top Page
China BlueChemical
(3983)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$2.00
▲(2.04% Upside)
Action:Reiterated
Date:08/21/26
The score is driven primarily by mixed financial performance: strong balance sheet strength and positive (improving) free cash flow are offset by a sharp 2025 revenue decline and weaker margins, elevating cyclicality risk. Technically, the stock shows a clear bearish trend (below key moving averages with weak RSI/MACD), which weighs on the score. Valuation is a relative positive due to the low P/E and high dividend yield.
Positive Factors
Conservative balance sheet
Very low leverage and a stable or expanding equity base give China BlueChemical financial flexibility. This capital strength can help absorb fertilizer-cycle volatility, support maintenance investment, and reduce refinancing pressure during weaker demand periods.
Negative Factors
Sharp revenue contraction
The steep 2025 revenue decline highlights substantial exposure to fertilizer volumes, prices, and market cycles. Such contraction reduces earnings visibility and makes near-to-medium-term performance dependent on a recovery in demand, pricing, or production utilization.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and a stable or expanding equity base give China BlueChemical financial flexibility. This capital strength can help absorb fertilizer-cycle volatility, support maintenance investment, and reduce refinancing pressure during weaker demand periods.
Read all positive factors
China BlueChemical (3983) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$9.06B
Dividend Yield6.42%
Average Volume (3M)4.79M
Price to Earnings (P/E)9.4
Beta (1Y)0.54
Revenue Growth3.52%
EPS Growth-14.56%
CountryHK
Employees3,601
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)0.18
Shares Outstanding1,796,000,100
10 Day Avg. Volume5,713,043
30 Day Avg. Volume4,791,562
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)0.53
Price to Sales (P/S)0.83
P/FCF Ratio10.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$2.99Price Target Upside52.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.31
Revenue Forecast (FY)HK$14.04B
China BlueChemical Business Overview & Revenue Model
Company Description
China BlueChemical Ltd., along with its affiliated entities, focuses on the development, production, and worldwide distribution of mineral fertilizers and various chemical commodities. The company's operations span both the People's Republic of Ch...
How the Company Makes Money
China BlueChemical makes money mainly by producing and selling fertilizers and related chemical products. Its revenue model is primarily volume-and-price driven: it manufactures standardized commodities (notably nitrogen fertilizers such as urea, ...
China BlueChemical Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
78
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.80B | 12.03B | 11.95B | 12.99B | 14.28B | 13.40B |
| Gross Profit | 1.52B | 1.57B | 1.70B | 2.06B | 2.54B | 2.94B |
| EBITDA | 1.09B | 1.29B | 1.55B | 3.33B | 2.35B | 2.76B |
| Net Income | 841.33M | 974.44M | 1.07B | 2.38B | 1.64B | 1.50B |
Balance Sheet | ||||||
| Total Assets | 24.77B | 24.85B | 24.08B | 24.32B | 23.50B | 21.43B |
| Cash, Cash Equivalents and Short-Term Investments | 14.01B | 14.04B | 13.51B | 13.19B | 12.55B | 11.23B |
| Total Debt | 2.43B | 2.11B | 2.12B | 2.02B | 2.08B | 1.05B |
| Total Liabilities | 5.03B | 4.87B | 4.57B | 4.91B | 5.72B | 4.52B |
| Stockholders Equity | 18.82B | 18.84B | 18.41B | 18.30B | 16.75B | 15.83B |
Cash Flow | ||||||
| Free Cash Flow | 531.56M | 965.97M | 918.02M | 800.48M | 806.70M | 1.88B |
| Operating Cash Flow | 870.77M | 1.38B | 1.52B | 1.54B | 2.14B | 2.94B |
| Investing Cash Flow | -401.69M | -570.50M | -379.00M | -691.13M | -2.35B | -3.66B |
| Financing Cash Flow | -252.95M | -751.44M | -1.06B | -784.06M | 56.35M | -1.37B |
China BlueChemical Technical Analysis
Negative
1.96
Price Trends
2.07
Negative
2.21
Negative
2.37
Negative
Market Momentum
-0.04
Negative
45.97
Neutral
76.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3983, the sentiment is Negative. The current price of 1.96 is below the 20-day moving average (MA) of 2.02, below the 50-day MA of 2.07, and below the 200-day MA of 2.37, indicating a bearish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 45.97 is Neutral, neither overbought nor oversold. The STOCH value of 76.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3983.
China BlueChemical Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$9.48B | 6.55 | 11.35% | 6.73% | 16.17% | 26.33% | |
64 Neutral | HK$14.74B | 9.19 | 12.16% | 3.45% | 24.29% | -7.52% | |
62 Neutral | HK$9.06B | 9.38 | 4.47% | 6.42% | 3.52% | -14.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$4.73B | 5.32 | 13.63% | 1.23% | 0.90% | 16.54% | |
40 Underperform | HK$8.49B | 30.70 | 1.87% | 0.23% | -1.80% | ― |
* Basic Materials Sector Average
HK:3983
China BlueChemical
2.00
-0.27
-12.09%
HK:0297
Sinofert Holdings
1.40
-0.02
-1.20%
HK:1866
China XLX Fertiliser Ltd.
10.74
3.53
48.94%
HK:0509
Century Sunshine Group Holdings Limited
0.17
0.00
0.00%
HK:1907
China Risun Group Ltd.
1.93
-0.57
-22.65%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
4.05
2.31
133.16%
China BlueChemical Corporate Events
China BlueChemical Posts Solid Interim Profit Despite Higher Impairment Charges
Aug 19, 2026
China BlueChemical reported interim revenue of RMB5,619 million for the six months ended 30 June 2026, with gross profit of RMB798 million and profit attributable to owners of RMB507 million, translating into basic earnings per share of RMB0.11. W...
China BlueChemical Schedules Board Meeting to Approve Interim Results
Aug 4, 2026
China BlueChemical Ltd., a PRC-incorporated joint stock company listed in Hong Kong under stock code 3983, has announced that its board of directors will convene in mid-August to review corporate performance. The company’s governance framewo...
China BlueChemical Shareholders Approve All AGM Resolutions and Capital Mandates
May 28, 2026
China BlueChemical reported that all resolutions proposed at its 2025 annual general meeting, as well as at separate class meetings for H shareholders and domestic shareholders, were duly passed. Shareholder participation was strong, with about 76...
China BlueChemical Sets Final 2025 Dividend and Confirms Withholding Tax Terms
May 28, 2026
China BlueChemical has declared a final ordinary dividend of RMB 0.112 per share for the financial year ended 31 December 2025, with shareholders’ approval obtained on 28 May 2026. For Hong Kong shareholders, the dividend will be paid in Hon...
China BlueChemical Changes Venue for 28 May 2026 Shareholder Meetings
May 21, 2026
China BlueChemical has announced a change in the venue for its annual general meeting, as well as its H shareholders’ and domestic shareholders’ class meetings, all scheduled for 28 May 2026. The meetings will now be held at the 1st Fl...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.